Understanding Skin Cancer -- the Basics
From symptoms to prevention, get the basics on skin cancer from the experts at WebMD.
10 Questions to Ask Your Doctor About Melanoma
If you've just been diagnosed with melanoma, you have questions. WebMD experts provide 10 questions you might want to ask your doctor.
Melanoma Treatment (PDQ®): Treatment - Patient Information [NCI] - General Information About Melanoma
Melanoma is a disease in which malignant (cancer) cells form in the skin cells called melanocytes (cells that color the skin). Melanocytes are found throughout the lower part of the epidermis. They produce melanin,the pigment that gives skin its natural color. When skin is exposed to the sun,melanocytes produce more pigment,causing the skin to tan,or darken. The skin is the body’s largest ..
Melanoma Treatment (PDQ®): Treatment - Patient Information [NCI] - General Information About Metastatic Squamous Neck Cancer with Occult Primary
Metastatic squamous neck cancer with occult primary is a disease in which squamous cell cancer spreads to lymph nodes in the neck and it is not known where the cancer first formed in the body. Squamous cells are thin,flat cells found in tissues that form the surface of the skin and the lining of body cavities such as the mouth,hollow organs such as the uterus and blood vessels,and the lining ...
Genetics of Skin Cancer (PDQ®): Genetics - Health Professional Information [NCI] - Changes to This Summary (08 / 25 / 2014)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above. Editorial changes were made to this summary.
Melanoma Treatment (PDQ®): Treatment - Patient Information [NCI] - About This PDQ Summary
Purpose of This SummaryThis PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about skin cancer screening. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care decisions.Reviewers and UpdatesThis summary is reviewed regularly and updated as necessary by the PDQ Screening and Prevention Editorial Board, which is editorially independent of the National Cancer Institute (NCI). The summary reflects an independent review of the literature and does not represent a policy statement of NCI or the National Institutes of Health (NIH). Board members review recently published articles each month to determine whether an article should:be discussed at a meeting,be cited with text, orreplace or update an existing article that is already cited.Changes to the summaries are made through a consensus process in which
Melanoma Treatment (PDQ®): Treatment - Patient Information [NCI] - Get More Information From NCI
Call 1-800-4-CANCERFor more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 a.m. to 8:00 p.m., Eastern Time. A trained Cancer Information Specialist is available to answer your questions.Chat online The NCI's LiveHelp® online chat service provides Internet users with the ability to chat online with an Information Specialist. The service is available from 8:00 a.m. to 11:00 p.m. Eastern time, Monday through Friday. Information Specialists can help Internet users find information on NCI Web sites and answer questions about cancer. Write to usFor more information from the NCI, please write to this address:NCI Public Inquiries Office9609 Medical Center Dr. Room 2E532 MSC 9760Bethesda, MD 20892-9760Search the NCI Web siteThe NCI Web site provides online access to information on cancer, clinical trials, and other Web sites and organizations that offer support
Melanoma Treatment (PDQ®): Treatment - Patient Information [NCI] - Interventions With Inadequate Evidence as to Whether They Reduce Risk of Melanoma
Sunscreen Use and Ultraviolet (UV) Radiation AvoidanceBenefitsThere is inadequate evidence to determine whether the avoidance of sunburns or the use of sunscreen alters the incidence of cutaneous melanoma.Magnitude of Benefit: Unknown.Study Design: Primarily cohort or case-control studies. A post hoc analysis of one randomized controlled trial of regular sunscreen use versus use at the personal discretion of the control group suggested a possible decrease in melanoma in the regular sunscreen group that emerged years after the trial period ended. However, the numbers were extremely small, and the confidence intervals were consequently very large.Internal Validity: Poor.Consistency: Poor.External Validity: Not applicable (N/A).HarmsThe harms of sunscreen use are poorly quantified but are likely to be small, including allergic reactions to skin creams and lower production of vitamin D by the skin with less sun exposure.References: Thomas VD, Aasi SZ, Wilson LD, et al.: Cancer of the
Melanoma Treatment (PDQ®): Treatment - Patient Information [NCI] - General Information About Intraocular (Uveal) Melanoma Treatment
Incidence and MortalityMelanoma of the uveal tract (iris, ciliary body, and choroid), though rare, is the most common primary intraocular malignancy in adults. The mean age-adjusted incidence of uveal melanoma in the United States is approximately 4.3 new cases per million population, with no clear variation by latitude. Males have a higher incidence than females (4.9 vs. 3.7 per million). The age-adjusted incidence of this cancer has remained stable since at least the early 1970s.[1,2] U.S. incidence rates are low compared with the rates of other reporting countries, which vary from about 5.3 to 10.9 cases per million. Some of the variation may be the result of differences in inclusion criteria and methods of calculation.Uveal melanoma is diagnosed mostly at older ages, with a progressively rising, age-specific, incidence rate that peaks near the age of 70 years. Host susceptibility factors associated with the development of this cancer include:[2,3,4]Caucasian race.Light
Melanoma Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Resectable Stage III Melanoma Treatment
Stage III melanoma is defined by the American Joint Committee on Cancer's TNM classification system:Any T, N1, M0Any T, N2, M0Any T, N3, M0Standard Treatment Options for Patients With Stage III MelanomaWide local excision of the primary tumor with 1 cm to 3 cm margins, depending on tumor thickness and location.[2,3,4,5,6,7,8] Skin grafting may be necessary to close the resulting defect.High-dose or pegylated interferon alpha-2b as adjuvant treatment for patients who have undergone a complete surgical resection but are considered to be at high risk for relapse.Ipilimumab for patients with unresectable disease.Vemurafenib for patients with unresectable disease who test positive for the BRAF V600 mutation in a U.S. Food and Drug Administration-approved test.Adjuvant Treatment Options for Patients With Resected Stage III DiseaseProspective, randomized, multicenter treatment trials have demonstrated that high-dose interferon alpha-2b and pegylated interferon do not improve overall